thanks, page-11

Carrera, I'll go $1.15.
The board and its advisers, including the US board influenced members, have set the price at $1.07. Further to that , there are about 1.5M in-house options for sub 70C still available, and then 9M at $1.25 still to come. ( Not to mention the insto's options $1.26) Mix that in with a good dose of panic & stop losses, then we'll still be sitting twiddling our thumbs waiting for Hoy's prediction of 12 weeks from first dosing for safety news. I can't see first dosing now raising any excitement. It's lost its momentum & enthusiasm. Will one safety do much more in the light of all this chaos? It might limp along to efficacy over months, but don't expect any LT holders to be enlightened preferentially by this board of M&A experts. Sort of Cheers, Japes.